Ambalal Sarabhai

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE432A01017
  • NSEID:
  • BSEID: 500009
INR
27.02
2.21 (8.91%)
BSENSE

Mar 13

BSE+NSE Vol: 2.98 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 982753,
    "name": "Ambalal Sarabhai",
    "stock_name": "Ambalal Sarabhai",
    "full_name": "Ambalal Sarabhai Enterprises Ltd",
    "name_url": "stocks-analysis/ambalal-sarabhai",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "27.02",
    "chg": 2.21,
    "chgp": "8.91%",
    "dir": 1,
    "prev_price": "24.81",
    "mcapval": "189.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 500009,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE432A01017",
    "curr_date": "Mar 13",
    "curr_time": "",
    "bse_nse_vol": "2.98 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 13, 2026",
    "traded_date_str": "2026 03 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ambalal-sarabhai-982753-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Ambalal Sarabhai Enterprises Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ambalal-sarabhai-enterprises-ltd-is-rated-sell-3892051",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AmbalalSarabhai_mojoScore_3892051.png",
        "date": "2026-03-15 10:10:32",
        "description": "Ambalal Sarabhai Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Ambalal Sarabhai Enterprises Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ambalal-sarabhai-enterprises-ltd-is-rated-strong-sell-3866185",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AmbalalSarabhai_mojoScore_3866185.png",
        "date": "2026-03-03 10:10:34",
        "description": "Ambalal Sarabhai Enterprises Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Ambalal Sarabhai Enterprises Downgraded to Strong Sell Amid Technical and Fundamental Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ambalal-sarabhai-enterprises-downgraded-to-strong-sell-amid-technical-and-fundamental-weakness-3847863",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AmbalalSarabhai_mojoScore_3847863.png",
        "date": "2026-02-20 08:15:06",
        "description": "Ambalal Sarabhai Enterprises Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 19 Feb 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the stock’s overall outlook has worsened due to bearish technical trends, subpar valuation metrics, and disappointing long-term financial performance."
      },
      {
        "title": "Ambalal Sarabhai Enterprises Ltd Upgraded to Sell on Improving Financial and Technical Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ambalal-sarabhai-enterprises-ltd-upgraded-to-sell-on-improving-financial-and-technical-trends-3841893",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AmbalalSarabhai_mojoScore_3841893.png",
        "date": "2026-02-16 08:33:46",
        "description": "Ambalal Sarabhai Enterprises Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting notable improvements in its financial performance and technical outlook. Despite lingering challenges in long-term fundamentals, the company’s recent quarterly results and market behaviour have prompted a reassessment of its prospects, signalling cautious optimism among investors."
      },
      {
        "title": "Are Ambalal Sarabhai Enterprises Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-ambalal-sarabhai-enterprises-ltd-latest-results-good-or-bad-3838434",
        "imagepath": "",
        "date": "2026-02-13 20:20:31",
        "description": "Ambalal Sarabhai Enterprises Ltd reported its Q3 FY26 results, revealing a consolidated net profit of ₹3.64 crore, a significant turnaround from a loss in the previous quarter. This represents a substantial quarter-on-quarter growth of 750% and a year-on-year increase of 63.23%. Revenue for the same period reached ₹52.00 crore, marking a quarter-on-quarter growth of 16.99% and a year-on-year growth of 13.12%. \n\nThe operating profit, excluding other income, stood at ₹4.08 crore, with an operating margin of 7.85%, a notable recovery from just 1.15% in the previous quarter. However, this margin is still comparable to levels seen in Q4 FY25, indicating that while there has been recovery, operational performance remains constrained.\n\nDespite the positive quarterly results, there are concerns regarding earnings quality, as nearly 39% of the operating profit was derived from non-operating income. This raises quest..."
      },
      {
        "title": "Ambalal Sarabhai Q3 FY26: Profit Surge Masks Deeper Operational Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/ambalal-sarabhai-q3-fy26-profit-surge-masks-deeper-operational-concerns-3837555",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AmbalalSarabhai_quaterlyResult_3837555.png",
        "date": "2026-02-12 21:54:22",
        "description": "Ambalal Sarabhai Enterprises Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹201.00 crores, reported consolidated net profit of ₹3.64 crores in Q3 FY26, marking a dramatic turnaround from the ₹0.56 crore loss in Q2 FY26. However, beneath the headline recovery lies a troubling narrative of margin compression, heavy reliance on non-operating income, and persistent operational weakness that has pushed the stock down 48.30% over the past year."
      },
      {
        "title": "Are Ambalal Sarabhai Enterprises Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-ambalal-sarabhai-enterprises-ltd-latest-results-good-or-bad-3835868",
        "imagepath": "",
        "date": "2026-02-12 19:58:59",
        "description": "The latest financial results for Ambalal Sarabhai Enterprises Ltd for the quarter ended September 2025 reveal significant operational challenges. The company reported a consolidated net profit of ₹-0.56 crores, marking a notable decline compared to the previous quarter's profit of ₹8.22 crores. This represents a substantial reversal in profitability, indicating a concerning trend in financial performance.\n\nNet sales for the quarter were ₹44.45 crores, reflecting a quarter-on-quarter growth of 10.19% from ₹40.34 crores in the previous quarter. However, this growth is tempered by a slight year-on-year decline of 0.56% from ₹44.70 crores in the same quarter last year. The increase in sales did not translate into improved profitability, as the operating profit before depreciation, interest, tax, and other income (PBDIT excluding other income) fell sharply to ₹0.51 crores from ₹1.48 crores in the prior quarter, ..."
      },
      {
        "title": "Ambalal Sarabhai Enterprises Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ambalal-sarabhai-enterprises-ltd-is-rated-strong-sell-3827294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AmbalalSarabhai_mojoScore_3827294.png",
        "date": "2026-02-08 10:10:17",
        "description": "Ambalal Sarabhai Enterprises Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 02 June 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 February 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      },
      {
        "title": "When is the next results date for Ambalal Sarabhai Enterprises Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-ambalal-sarabhai-enterprises-ltd-3823221",
        "imagepath": "",
        "date": "2026-02-05 23:18:14",
        "description": "The next results date for Ambalal Sarabhai Enterprises Ltd is scheduled for 12 February 2026...."
      }
    ],
    "total": 139,
    "sid": "982753",
    "stock_news_url": "https://www.marketsmojo.com/news/ambalal-sarabhai-enterprises-982753"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Feb-2026",
      "details": "We here by submit Newspaper publication under Regulation 30 and 47 of SEBI (LODR) Regulations 2015. Kindly take the same on your records.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "12-Feb-2026",
      "details": "We hereby submit the Outcome of Board Meeting held on 12.02.2026. Kindly take the same on your records.",
      "source": "BSE"
    },
    {
      "caption": "Results - Financial Results For The Quarter And Nine Months Ended On 31.12.2025",
      "datetime": "12-Feb-2026",
      "details": "We hereby submit financial Result (Standalone and Consolidated) for the quarter and nine months ended 31.12.2025 along with Limited Review Report of Auditors thereon. Kindly take the same on your records.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

16-Feb-2026 | Source : BSE

We here by submit Newspaper publication under Regulation 30 and 47 of SEBI (LODR) Regulations 2015. Kindly take the same on your records.

Board Meeting Outcome for Outcome Of Board Meeting

12-Feb-2026 | Source : BSE

We hereby submit the Outcome of Board Meeting held on 12.02.2026. Kindly take the same on your records.

Results - Financial Results For The Quarter And Nine Months Ended On 31.12.2025

12-Feb-2026 | Source : BSE

We hereby submit financial Result (Standalone and Consolidated) for the quarter and nine months ended 31.12.2025 along with Limited Review Report of Auditors thereon. Kindly take the same on your records.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available